Drug Discovery Services Market worth US$27.23 billion in 2030 with 10.7% CAGR | MarketsandMarkets™ [Yahoo! Finance]
Charles River Laboratories International, Inc. (CRL)
Last charles river laboratories international, inc. earnings: 2/11 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.criver.com
Company Research
Source: Yahoo! Finance
grow at a robust CAGR of 10.7%, reaching US$16.36 billion in 2025 and an impressive US$27.23 billion by 2030. Growing R&D expenditure from drug pharmaceutical and biopharmaceutical companies, the increasing R&D pipeline creating a need for increased analytical testing outsourcing, initiatives for research on rare diseases and orphan drugs, and the high cost of in-house drug development are contributing to market growth. In addition, technological advancements, the development of new drug discovery techniques, the expiration of patents, and the increasing demand for specialized testing services among end users present further avenues for growth. Key segments positively impacting the market include chemistry services, with the
Read more
Impact Snapshot
Event Time:
CRL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRL alerts
High impacting Charles River Laboratories International, Inc. news events
Weekly update
A roundup of the hottest topics
CRL
News
- Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform [Yahoo! Finance]Yahoo! Finance
- Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery PlatformBusiness Wire
- Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "buy" rating to a "neutral" rating. They now have a $170.00 price target on the stock, down previously from $19MarketBeat
- 3 Reasons CRL is Risky and 1 Stock to Buy Instead [Yahoo! Finance]Yahoo! Finance
- Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Recent Stock Performance Influenced By Its Fundamentals In Any Way? [Yahoo! Finance]Yahoo! Finance
CRL
Earnings
- 2/19/25 - Beat
CRL
Sec Filings
- 2/26/25 - Form 4
- 2/21/25 - Form 4
- 2/21/25 - Form 4
- CRL's page on the SEC website